loadpatents
Patent applications and USPTO patent grants for Kayser; Frank.The latest application filed is for "cd73 inhibitors".
Patent | Date |
---|---|
CIS-morpholinone and other compounds as MDM2 inhibitors for the treatment of cancer Grant 11,407,721 - Bartberger , et al. August 9, 2 | 2022-08-09 |
Cd73 Inhibitors App 20220204539 - BAILEY; Simon ;   et al. | 2022-06-30 |
Cd73 Inhibitors App 20220185832 - BAILEY; Simon ;   et al. | 2022-06-16 |
Aromatic Derivatives, Preparation Methods, And Medical Uses Thereof App 20220169634 - WANG; Ding ;   et al. | 2022-06-02 |
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer App 20220169611 - Bartberger; Michael D. ;   et al. | 2022-06-02 |
Coxib-derived Conjugate Compounds And Methods Of Use Thereof App 20220133918 - SILBER; B. Michael ;   et al. | 2022-05-05 |
Aromatic derivative, preparation method for same, and medical applications thereof Grant 11,279,697 - Shao , et al. March 22, 2 | 2022-03-22 |
Conjugates Derived From Non-steroidal Anti-inflammatory Drugs And Methods Of Use Thereof In Imaging App 20220017432 - REILEY; Mark A. ;   et al. | 2022-01-20 |
Heteroaryl-substituted triazoles as APJ receptor agonists Grant 11,046,680 - Chen , et al. June 29, 2 | 2021-06-29 |
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer App 20210179560 - Bartberger; Michael D. ;   et al. | 2021-06-17 |
Broad Spectrum Antiviral Compositions and Methods App 20210139475 - Remiszewski; Stacy ;   et al. | 2021-05-13 |
Aromatic Derivative, Preparation Method For Same, And Medical Applications Thereof App 20200262827 - SHAO; Ning ;   et al. | 2020-08-20 |
Triazole furan compounds as agonists of the APJ receptor Grant 10,736,883 - Brown , et al. A | 2020-08-11 |
Ion channel inhibitory compounds, pharmaceutical formulations, and uses Grant 10,562,857 - Xie , et al. Feb | 2020-02-18 |
Triazole Furan Compounds As Agonists Of The Apj Receptor App 20190275008 - BROWN; Matthew ;   et al. | 2019-09-12 |
Conjugates Derived From Non-steroidal Anti-inflammatory Drugs And Methods Of Use Thereof In Imaging App 20190169084 - REILEY; Mark A. ;   et al. | 2019-06-06 |
Triazole agonists of the APJ receptor Grant 10,221,162 - Chen , et al. | 2019-03-05 |
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer App 20190062276 - Bartberger; Michael D. ;   et al. | 2019-02-28 |
Cis-morpholinone And Other Compounds As Mdm2 Inhibitors For The Treatment Of Cancer App 20180354918 - BARTBERGER; Michael D. ;   et al. | 2018-12-13 |
Triazole Agonists Of The Apj Receptor App 20180319773 - CHEN; Ning ;   et al. | 2018-11-08 |
Ion Channel Inhibitory Compounds, Pharmaceutical Formulations, and Uses App 20180312471 - Xie; Xinmin ;   et al. | 2018-11-01 |
Conjugates Derived From Non-steroidal Anti-inflammatory Drugs And Methods Of Use Thereof In Imaging App 20180162784 - REILEY; Mark A. ;   et al. | 2018-06-14 |
Triazole agonists of the APJ receptor Grant 9,868,721 - Chen , et al. January 16, 2 | 2018-01-16 |
Conjugates derived from non-steroidal anti-inflammatory drugs and methods of use thereof in imaging Grant 9,850,183 - Reiley , et al. December 26, 2 | 2017-12-26 |
Triazole agonists of the APJ receptor Grant 9,745,286 - Chen , et al. August 29, 2 | 2017-08-29 |
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer App 20170144971 - BARTBERGER; Michael D. ;   et al. | 2017-05-25 |
Triazole agonists of the APJ receptor Grant 9,656,997 - Chen , et al. May 23, 2 | 2017-05-23 |
Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer Grant 9,593,129 - Bartberger , et al. March 14, 2 | 2017-03-14 |
Triazole agonists of the APJ receptor Grant 9,573,936 - Chen , et al. February 21, 2 | 2017-02-21 |
Triazole Agonists Of The Apj Receptor App 20170042871 - Chen; Ning ;   et al. | 2017-02-16 |
Triazole Agonists Of The Apj Receptor App 20170042872 - CHEN; Ning ;   et al. | 2017-02-16 |
Triazole Agonists Of The Apj Receptor App 20170044131 - CHEN; Ning ;   et al. | 2017-02-16 |
Triazole Agonists Of The Apj Receptor App 20170042897 - Chen; Ning ;   et al. | 2017-02-16 |
Triazole Agonists Of The Apj Receptor App 20170035744 - CHEN; Ning ;   et al. | 2017-02-09 |
Triazole Agonists Of The Apj Receptor App 20170037026 - CHEN; Ning ;   et al. | 2017-02-09 |
Triazole Agonists Of The Apj Receptor App 20160340336 - Chen; Ning ;   et al. | 2016-11-24 |
Heterocyclic compounds as MDM2 inhibitors for the treatment of cancer Grant 9,376,425 - Bartberger , et al. June 28, 2 | 2016-06-28 |
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer App 20160137667 - BARTBERGER; Michael D. ;   et al. | 2016-05-19 |
Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer Grant 9,296,736 - Bartberger , et al. March 29, 2 | 2016-03-29 |
Cis-morpholinone And Other Compounds As Mdm2 Inhibitors For The Treatment Of Cancer App 20160002185 - BARTBERGER; Michael D. ;   et al. | 2016-01-07 |
Conjugates Derived From Non-steroidal Anti-inflammatory Drugs And Methods Of Use Thereof In Imaging App 20150374858 - REILEY; Mark A. ;   et al. | 2015-12-31 |
Piperidinone Derivatives As Mdm2 Inhibitors For The Treatment Of Cancer App 20140315895 - Bartberger; Michael D. ;   et al. | 2014-10-23 |
Heterocyclic Compounds As Mdm2 Inhibitors For The Treatment Of Cancer App 20140235629 - Bartberger; Michael D. ;   et al. | 2014-08-21 |
Piperidinone Derivatives As Mdm2 Inhibitors For The Treatment Of Cancer App 20140011796 - BARTBERGER; Michael David ;   et al. | 2014-01-09 |
Methods For Treating Atherosclerosis App 20130273024 - KAYSER; Frank ;   et al. | 2013-10-17 |
Methods for treating atherosclerosis Grant 8,426,358 - Kayser , et al. April 23, 2 | 2013-04-23 |
Piperidinone Derivatives As Mdm2 Inhibitors For The Treatment Of Cancer App 20110319378 - BARTBERGER; Michael David ;   et al. | 2011-12-29 |
Methods For Treating Atherosclerosis App 20110206652 - Kayser; Frank ;   et al. | 2011-08-25 |
Furanopyrimidines Grant 7,776,867 - Buchanan , et al. August 17, 2 | 2010-08-17 |
Substituted pyrazolo[3,4-d]pyrimidines as ACK-1 and LCK inhibitors Grant 7,763,624 - Buchanan , et al. July 27, 2 | 2010-07-27 |
Furanopyridine derivatives and methods of use Grant 7,674,907 - Nunes , et al. March 9, 2 | 2010-03-09 |
Linked biaryl compounds Grant 7,645,779 - Abe , et al. January 12, 2 | 2010-01-12 |
FXR modulators Grant 7,511,043 - Houze , et al. March 31, 2 | 2009-03-31 |
Heterocyclic arylsulfonamidobenzylic compounds Grant 7,473,703 - Jiao , et al. January 6, 2 | 2009-01-06 |
Linked biaryl compounds App 20080161351 - Abe; Hiroyuki ;   et al. | 2008-07-03 |
Methods for treating atherosclerosis App 20080096900 - Kayser; Frank ;   et al. | 2008-04-24 |
Pyrrolo[2,3-d]pyrimidines that modulate ACK1 activity Grant 7,358,250 - Farthing , et al. April 15, 2 | 2008-04-15 |
Arylsulfonamidobenzylic compounds Grant 7,326,812 - Jiao , et al. February 5, 2 | 2008-02-05 |
Pyrrolo[1,2-b]pyridazine derivatives Grant 7,300,932 - Fox , et al. November 27, 2 | 2007-11-27 |
Fused Bicyclic Nitrogen-Containing Heterocycles App 20070244096 - Fox; Brian M. ;   et al. | 2007-10-18 |
Fused bicyclic nitrogen-containing heterocycles Grant 7,244,727 - Fox , et al. July 17, 2 | 2007-07-17 |
Pyrazolopyridine and pyrazolopyrimidine compounds App 20070072851 - Buchanan; John L. ;   et al. | 2007-03-29 |
Heterocyclic arylsulfonamidobenzylic compounds App 20060270718 - Jiao; Xian Yun ;   et al. | 2006-11-30 |
Arylsulfonamidobenzylic compounds App 20060264424 - Harrison; Martin J. ;   et al. | 2006-11-23 |
Heterocyclic arylsulfonamidobenzylic compounds Grant 7,112,606 - Jiao , et al. September 26, 2 | 2006-09-26 |
Arylsulfonamidobenzylic compounds Grant 7,071,358 - Jiao , et al. July 4, 2 | 2006-07-04 |
Arylsulfonamidobenzylic compounds App 20060122239 - Jiao; Xian Yun ;   et al. | 2006-06-08 |
Furanopyridine derivatives and methods of use App 20060046977 - Nunes; Joseph J. ;   et al. | 2006-03-02 |
Pyrrolo[2,3-d]pyrimidines that modulate ACK1 activity App 20060040965 - Farthing; Christopher N. ;   et al. | 2006-02-23 |
Furanopyrimidines App 20060040961 - Buchanan; John Laird ;   et al. | 2006-02-23 |
Pyrrolo[1,2-b]pyridazine derivatives App 20050070545 - Fox, Brian M. ;   et al. | 2005-03-31 |
Linked biaryl compounds Grant 6,869,975 - Abe , et al. March 22, 2 | 2005-03-22 |
Fused bicyclic nitrogen-containing heterocycles App 20040209871 - Fox, Brian M. ;   et al. | 2004-10-21 |
FXR modulators App 20040176426 - Houze, Jonathan ;   et al. | 2004-09-09 |
FXR modulators Grant 6,777,446 - Houze , et al. August 17, 2 | 2004-08-17 |
Arylsulfonamidobenzylic compounds App 20030229093 - Jiao, Xian Yun ;   et al. | 2003-12-11 |
Heterocyclic arylsulfonamidobenzylic compounds App 20030220339 - Jiao, Xian Yun ;   et al. | 2003-11-27 |
Carbocyclic potassium channel inhibitors Grant 6,632,836 - Baker , et al. October 14, 2 | 2003-10-14 |
Linked biaryl compounds App 20030149108 - Abe, Hiroyuki ;   et al. | 2003-08-07 |
FXR modulators App 20020120137 - Houze, Jonathan ;   et al. | 2002-08-29 |
4-alkyl piperidinyl pyrrolidine modulators of chemokine receptor activity App 20020013348 - Chee, Jennifer ;   et al. | 2002-01-31 |
Method and device for producing a coke coal cake for carrying out a coking process in a furnace chamber Grant 6,332,957 - Gross , et al. December 25, 2 | 2001-12-25 |
3-thienyl and 3-furanyl pyrrolidine modulators of chemokine receptor activity Grant 6,303,593 - Bao , et al. October 16, 2 | 2001-10-16 |
Triterpene derivatives with immunosuppressant activity Grant 5,952,371 - Baker , et al. September 14, 1 | 1999-09-14 |
Triterpene derivatives with immunosuppressant activity Grant 5,763,478 - Baker , et al. June 9, 1 | 1998-06-09 |
Triterpene derivatives with immunosuppressant activity Grant 5,696,156 - Baker , et al. December 9, 1 | 1997-12-09 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.